Abstract
Exercise and pharmacologic therapies to prevent and treat cardiovascular disease have advanced largely through independent efforts. Understanding of first-line drug therapies, findings from preclinical animal studies, and the need for research initiatives related to complementary cardioprotective exercise-pharma interventions are reviewed from the premise that contemporary cardioprotective therapies must include adjunctive exercise and lifestyle interventions in addition to pharmacologic agents.
Original language | English |
---|---|
Pages (from-to) | 5-17 |
Number of pages | 13 |
Journal | Exercise and Sport Sciences Reviews |
Volume | 46 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1 2018 |
Keywords
- cardioprotection
- heart disease
- ischemia-reperfusion injury
- pharmacotherapy
- preconditioning